Weiss Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-5,410
Closed -$397K – 701
2025
Q3
$397K Sell
5,410
-205,842
-97% -$13.7M ﹤0.01% 492
2025
Q2
$11M Buy
+211,252
New +$12M 0.13% 105
2018
Q4
– Sell
-20,814
Closed -$378K – 465
2018
Q3
$378K Hold
20,814
– – 0.03% 124
2018
Q2
$351K Hold
20,814
– – 0.03% 125
2018
Q1
$408K Hold
20,814
– – 0.03% 127
2017
Q4
$422K Buy
+20,814
New +$383K 0.04% 138

Other funds holding HALO

Weiss Asset Management's HALO Position: Q4 2025 in Review

Weiss Asset Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 5,410 shares — an estimated $397K sold.

Weiss Asset Management first reported a position in HALO in Q4 2017 and held it in 6 quarters. The position peaked at $11M in Q2 2025. 619 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Weiss Asset Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Weiss Asset Management sold 5,410 Halozyme shares in Q4 2025, an estimated $397K.
  • Weiss Asset Management first reported a position in Halozyme in Q4 2017 and held it in 6 quarters.
  • Weiss Asset Management's Halozyme position peaked at $11M in Q2 2025.
  • 619 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Weiss Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.